期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 59, 期 12, 页码 5604-5621出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.5b01599
关键词
-
资金
- GlaxoSmithKline
- University of Strathclyde
The autotaxin-lysophophatidic acid (ATX-LPA) signaling pathway is implicated in a variety of human disease states including angiogenesis, autoimmune diseases, cancer, fibrotic diseases, inflammation, neurodegeneration, and neuropathic pain, among others. As a result, ATX-LPA has become of significant interest within both the industrial and the academic communities. This review aims to provide a concise overview of the development of novel ATX inhibitors, including the disclosure of the first ATX clinical trial data.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据